EUVIMEDEUVIMED entdecken
Crossref

CDK9 regulates neointima formation following vascular injury by targeting the transcription factor Twist1

Liqing Yu, Xiaoxia Zhou, Jiafeng Chen, Mengxiang Li, Ruiying Wang, Gang Li, Jun Wu

International Journal of Molecular Medicine · 20.11.2026 · 59 (1) · 1-16

DOI: 10.3892/ijmm.2026.6063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 20.11.2026. Verfasst von Liqing Yu und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Restenosis is a major limiting factor of percutaneous coronary intervention, accompanied by abnormal proliferation, migration and phenotypic switching of vascular smooth muscle cells (VSMCs). As a key component of the positive transcription elongation factor b complex, cyclin‑dependent kinase 9 (CDK9) phosphorylates RNA polymerase II (RNA Pol II) and regulates various genes that are involved in the regulation of diverse cellular processes, including cell proliferation. The present study aimed to investigate whether and how CDK9 regulates vascular remodeling after injury in mice. Carotid artery ligation was performed in C57BL/6J mice, and cultured VSMCs were treated with platelet‑derived growth factor‑BB, iCDK9, Thal‑SNS‑032, harmine or CDK9‑overexpressing recombinant adenovirus. Neointimal formation, proliferation, migration and phenotypic switching were examined by histological quantification, western blotting, reverse transcription‑quantitative PCR, 5‑ethynyl‑2'‑deoxyuridine incorporation, wound‑healing and immunofluorescence assays, and the mechanism was explored by RNA‑sequencing, chromatin immunoprecipitation and luciferase reporter assays. The results revealed a notable upregulation of CDK9 and the phosphorylation of RNA Pol II at Ser2 in VSMCs during neointimal hyperplasia following carotid artery injury, and the neointimal formation could be markedly ameliorated by a CDK9 inhibitor. Furthermore, overexpression of CDK9 promoted the phenotypic switching, proliferation and migration of VSMCs in vitro , whereas inhibition of CDK9 produced the opposite results. Furthermore, CDK9 exerted its biological function by directly targeting the transcription factor Twist1, which is a key inducer of epithelial‑mesenchymal transition that has been widely implicated in the pathological progression of cardiovascular diseases. Additionally, application of the Twist1 inhibitor harmine markedly abolished the function of CDK9 in promoting the phenotypic switching, proliferation and migration of VSMCs in vitro . In conclusion, the present study explored the function of CDK9 in vascular injury‑induced neointimal hyperplasia and established that CDK9 may exert direct targeting regulation on the transcription factor Twist1 within this pathological cascade.

Zitieren

APA

Yu, L., Zhou, X., Chen, J., Li, M., Wang, R., Li, G., & Wu, J. (2026). CDK9 regulates neointima formation following vascular injury by targeting the transcription factor Twist1. International Journal of Molecular Medicine, 59(1), 1-16. https://doi.org/10.3892/ijmm.2026.6063

Vancouver

Yu L, Zhou X, Chen J, Li M, Wang R, Li G, et al. CDK9 regulates neointima formation following vascular injury by targeting the transcription factor Twist1. International Journal of Molecular Medicine. 2026;59(1):1-16. doi:10.3892/ijmm.2026.6063

BibTeX
@article{Yu2026,
  author = {Yu, Liqing and Zhou, Xiaoxia and Chen, Jiafeng and Li, Mengxiang and Wang, Ruiying and Li, Gang and Wu, Jun},
  title = {CDK9 regulates neointima formation following vascular injury by targeting the transcription factor Twist1},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  volume = {59},
  number = {1},
  pages = {1--16},
  doi = {10.3892/ijmm.2026.6063}
}
Kostenlos starten →